sixty-four patients receiving cancer chemotherapy known to induce severe emesis entered a randomized double-blind study of the antiemetic efficacy of haloperidol ( haldol ) and benzquinamide ( emetecon ) .
C0042963
emesis
C0018546
haloperidol